# The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

> **NCT06902818** · PHASE1 · COMPLETED · sponsor: **Addpharma Inc.** · enrollment: 46 (actual)

## Conditions studied

- Gastric Ulcer

## Interventions

- **DRUG:** AD-115A, AD-1151

## Key facts

- **NCT ID:** NCT06902818
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-21
- **Primary completion:** 2025-04-25
- **Final completion:** 2025-05-08
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06902818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06902818, "The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06902818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*